Ex vivo engineered immune organoids for controlled germinal center reactions
- 1 September 2015
- journal article
- research article
- Published by Elsevier in Biomaterials
- Vol. 63, 24-34
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (1R21CA185236-01)
- Cornell University and Weill Cornell Medical College
- Howard Hughes Medical Institute (HHMI 56006761)
This publication has 67 references indexed in Scilit:
- Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cellsLeukemia, 2011
- BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapyJournal of Clinical Investigation, 2010
- A Small-Molecule Inhibitor of BCL6 Kills DLBCL Cells In Vitro and In VivoCancer Cell, 2010
- A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6–dependent B cell lymphomasNature Medicine, 2009
- Photocrosslinking of Gelatin Macromers to Synthesize Porous Hydrogels That Promote Valvular Interstitial Cell FunctionTissue Engineering Part A, 2009
- In-situ crosslinking hydrogels for combinatorial delivery of chemokines and siRNA–DNA carrying microparticles to dendritic cellsBiomaterials, 2009
- A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivoBlood, 2009
- Sequential Transcription Factor Targeting for Diffuse Large B-Cell LymphomasCancer Research, 2008
- Splenic CD19−CD35+B220+ cells function as an inducer of follicular dendritic cell network formationBlood, 2007
- In vivo imaging of germinal centres reveals a dynamic open structureNature, 2007